MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

A Study to Assess the Effect of Smart Insulin Pens on Glycemic Control and Diabetes-related Burdens

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: InPen®

First Posted Date: 2021-09-05

Last Posted Date: 2024-01-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 13

Registration Number: NCT05036343

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

Recruiting

Conditions: Chondrosarcoma
Chordoma
Bone Sarcoma
Pelvic Rhabdomyosarcoma
Ewing Sarcoma of Bone

Interventions: Other: Electronic Health Record Review
Other: Quality-of-Life Assessment

First Posted Date: 2021-09-02

Last Posted Date: 2024-11-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 72

Registration Number: NCT05033288

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Phase 1

Recruiting

Conditions: Malignant Glioma

Interventions: Radiation: Radiation Therapy
Radiation: Radiosurgery
Procedure: Stereotactic Biopsy
Drug: Temozolomide
Procedure: Tumor Treating Fields Therapy
Procedure: Magnetic Resonance Imaging
Procedure: Biospecimen Collection
Procedure: Biopsy
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2021-09-01

Last Posted Date: 2024-10-31

Lead Sponsor: Mayo Clinic

Target Recruit Count: 25

Registration Number: NCT05030298

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients

Phase 2

Withdrawn

Conditions: Cardiac Disease

Interventions: Drug: Placebo
Drug: FEIBA

First Posted Date: 2021-08-25

Last Posted Date: 2022-12-05

Lead Sponsor: Mayo Clinic

Registration Number: NCT05020483

Remote Monitoring in Cancer Care: a Platform Study

Active, not recruiting

Conditions: Hematopoietic and Lymphoid Cell Neoplasm
Lung Carcinoma
Malignant Digestive System Neoplasm
Head and Neck Carcinoma
Malignant Solid Neoplasm

Interventions: Other: Computer-Assisted Intervention
Procedure: Patient Monitoring
Other: Questionnaire Administration

First Posted Date: 2021-08-24

Last Posted Date: 2025-01-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT05018208

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine

Completed

Conditions: Chronic Progressive External Ophthalmoplegia With Myopathy
Kearns-Sayre Syndrome
Mitochondrial DNA Mutation
Mitochondrial Myopathies
Mitochondrial Diseases

First Posted Date: 2021-08-19

Last Posted Date: 2024-06-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 9

Registration Number: NCT05012358

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Cardiac Rehab and Cerebral Blood Flow Study

Not Applicable

Recruiting

Conditions: Cardiovascular Diseases

Interventions: Behavioral: Cardiac rehabilitation - high intensity interval training (HIIT)
Behavioral: Cardiac rehabilitation - control
Behavioral: Cardiac rehabilitation - moderate intensity continuous training (MICT)
Behavioral: Cardiac rehabilitation - observational

First Posted Date: 2021-08-19

Last Posted Date: 2024-03-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 87

Registration Number: NCT05012878

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Sleep Apnea in Heart Failure With Preserved Ejection Fraction

Completed

Conditions: Obstructive Sleep Apnea
Heart Failure

Interventions: Diagnostic Test: Home sleep apnea testing

First Posted Date: 2021-08-17

Last Posted Date: 2024-08-28

Lead Sponsor: Mayo Clinic

Target Recruit Count: 48

Registration Number: NCT05008432

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques

Not Applicable

Active, not recruiting

Conditions: Tricuspid Regurgitation

Interventions: Diagnostic Test: Cardiac Magnetic Resonance

First Posted Date: 2021-08-16

Last Posted Date: 2024-03-29

Lead Sponsor: Mayo Clinic

Target Recruit Count: 75

Registration Number: NCT05006443

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty

Phase 4

Completed

Conditions: Pain, Postoperative
Brachial Plexus Block

Interventions: Drug: Liposomal bupivacaine + Bupivacaine Hcl 0.5% Inj
Drug: Bupivacaine HCl

First Posted Date: 2021-08-13

Last Posted Date: 2024-05-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 88

Registration Number: NCT05005260

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy